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Reply to “Letter to the Editor: Clinical implications
for the effect of glucosamine sulfate iontophoresis
on fasting plasma glucose levels”Ayodele Teslim Onigbinde, BMR PT, PhD a,*, Adetayo Ebun Talabi, PhD b,
Raheem Adaramaja Shehu, PhD b, Chidozie E. Mbada, MSc PT aaMedical Rehabilitation Department, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun State, Nigeria
bHuman Kinetics and Health Education Department, University of Ilorin, Ilorin, Kwara State, NigeriaWe appreciate the comments of Mohan and Joseph [1] on
our research work entitled “Acute effects of combination of
glucosamine sulfate iontophoresis with exercise on fasting
plasma glucose of participants with knee osteoarthritis.”
We wish to reply to their comments in order.
First and foremost, the research paper was a technical
report on a preliminary experimental study in a verdant
area in patient’ care, which may serve as a foundation for
future studies.
In our opinion, this study has potential clinical applica-
bility and usefulness in spite of its quasi-experimental
design. A quasi-experimental design approximates to
a true experimental design but with the limitation that it
does not allow a complete control of extraneous variables.
However, the quasi-experimental design is closer to reality
in clinical practice, and has higher external validity than
a classic randomized controlled design.
The electromotive drug administration (EMDA) process
for iontophoresis seems to be gaining wider acceptance
among physiotherapists, although it is still difficult, in most
clinical settings and research studies, to establish the
pharmacodynamic and pharmacokinetic properties of most
drugs administered via EMDA. Glucosamine has been used
clinically since 1960s, but its pharmacokinetics are not wellDOI of original article: 10.1016/j.hkpj.2011.11.001.
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assays. Consequently, more studies on the pharmacoki-
netics of glucosamine seem to be needed to help resolve
the controversial data generated from various clinical trials
[2]. In our study, the bioavailability of glucosamine could
not be determined because of a non-availability of high-
performance liquid chromatography assay and an inability
in our laboratory to carry out radioisotope labelling to
detect plasma glucosamine. Glucosamine is an amino sugar
that lacks chromophores, hence it is undetectable in the
ultravioletevisible light range, and most radiolabelled
compounds cannot differentiate between the parent
compound and its biosynthetic or degraded products [3].
It was assumed that the dose of 300 mg glucosamine
sulfate cream applied transdermally would be adequate
based on reported efficacy in terms of pain relief in
previous studies [4e6]. The trend of pain relief suggested
that the drug is bioavailable to exert therapeutic effects.
Lee et al strongly suggested that a high and sustainable
level of glucosamine in the blood could be achieved via
a topical application of Mediflex glucosamine cream and
was able to provide enzymes with a sufficient amount of
substrate for the processes of cartilage regeneration and
rehabilitation [4]. The implication is that the concentration
of glucosamine achieved via iontophoresis is likely to be
physiologically active and affect the glucose concentration.
Like most clinical trials involving human subjects seen
over a period of time, our study suffered from attrition,
thereby affecting our sample size. However, the sample
size used in this preliminary study was an improvement overserved.
5those of previous studies. The aerobic exercise carried out
on cycle ergometer in this study was unloaded considering
the subjects’ knee pathology, while maintaining uniformity
in time for 15 minutes. In addition, we encouraged all
participants, via a prerecorded audioverbal motivatory
message, to pedal as quickly as possible.
“Direct current” was a term formerly used for galvanic
current and was intended to be used synonymously in this
study. We believed that reverse iontophoresis has nothing
to do with current mode but may have an effect on the
charge of the drug or molecule when the skin is negatively
charged at a buffered pH.
The lower plasma glucose levels among the participants
in group 2 might be due to the effect of electrical muscle
stimulation. During electrical muscle stimulation, electrical
signals cause cross-bridge cycling between myosin and
actin, which generates force. There is an excitation and
reversing of contraction; and various activities that
requires energy [7]. Muscles use energy in the form of
Adenosine Tri-phosphate (ATP), and during aerobic respira-
tion in muscles, glucose, glycogen, fats and amino acids are
broken down in the presence of oxygen to produce more ATP
[7]. The combination of voluntary and electrical muscle
contractions have previously been observed to decrease
fasting blood glucose, although this was after 12 weeks’
training [8]. Muscle contraction compresses the blood vessels
within the muscle, resulting in diminished blood flow, which
will subsequently reduce the glucose level. Electrical muscle
contraction alone and insulin alone increased glucose uptake
significantly in a study by Brozinick et al [9], although this
was on rat skeletal muscle. Our study showed that, despite
the administration of the amino sugar glucosamine sulfate to
participants in group 2, there was still a further depletion of
plasma glucose concentration.
In conclusion, we appreciate the comments of Mohan
and Joseph on our study. We have noted the limitations
pointed out in the article, will definitely address these infuture studies, and look forward to collaborating with their
institution.References
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